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Abstract 
 
 Neonates face a dramatic transition at birth as they move from the protected womb to an 
environment full of foreign antigens. Due to limited prenatal exposure to antigens, newborns 
initially rely on their innate immune system for protection. Natural killer (NK) cells are large 
granular lymphocytes that protect the body against infections due to their ability to kill target 
cells as well as secrete inflammatory cytokines to further induce themselves or the neighboring 
immune cells to mount a protective response. NK cell populations in the blood of breast-fed 
infants are higher than in formula-fed infants, leading to the hypothesis that human milk 
components influence the development of NK cells. Lactoferrin (Lf) is a multifunctional 
glycoprotein found in high concentrations in human milk (2.1 g/L), but at 20-fold lower levels 
(100 mg/L) in bovine milk and infant formula. Lf has been shown to increase human NK cell 
cytotoxic activity when the cells were isolated and stimulated with Lf in vitro; however, the 
effect of dietary Lf on NK cell cytotoxicity was not known.  
The goal of this thesis was to investigate the effect of bovine Lf and vaccination on T-cell 
subpopulations and NK cell development in the neonate using the piglet as a model. Newborn 
piglets received 4h of colostrum and then were randomized to sow milk replacer formula (FF), 
formula supplemented with 1 g/L bovine Lf (LF), or sow-reared (SR). Half of the piglets in each 
diet group were vaccinated using a pediatric dose (0.25 mL) of Fluzone™ at postnatal d7 
followed by a booster on d14. On d21 postpartum, piglets were euthanized and blood and tissue 
samples were collected. Cells were isolated from blood, spleen and mesenteric lymph nodes 
(MLN) to identify T-cell subpopulations and NK cell populations by flow cytometry. NK cells 
were further isolated from peripheral blood mononuclear cells (PBMCs) and assessed in a NK 
cell cytotoxicity assay.  
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Body weight, T-cell subpopulations and NK cell cytotoxicity were not affected by 
vaccination; thus vaccination data for these analyses were pooled by diet group. The average 
body weight of SR piglets was significantly higher (p<0.05) than that of FF or LF piglets on d3-
21. On d21, average body weight of LF piglets was higher (p<0.05) than FF piglets, suggesting 
that bLf supplementation to formula may enhance growth of young animals.  
There was an interaction between the effect of diet and vaccination on NK cell 
population. Vaccination did not affect the number of NK cell population in PBMC of SR and LF 
animals. However, NK cell population size in PBMC changed after vaccination in FF animals. 
The NK cell population size of FF vaccinated (FFV) animals was significantly larger (p<0.05) 
than those of FF non-vaccinated (FFN), suggesting that PBMC NK cells from FF animals 
responded to Fluzone vaccination. However, diet did not affect NK cell population size in PBMC 
of the vaccinated animals. The percentage of NK cells in PBMC was not different between SR 
vaccinated (SRV), LF vaccinated (LFV) and FFV animals. Among non-vaccinated animals, diet 
had a significant effect on NK cell population size. SR non-vaccinated (SRN) animals had over 
twice as many NK cells than non-vaccinated FF (FFN) animals, whereas the NK cell population 
of non-vaccinated LF (LFN) was not significantly different from wither SRN or FFN. These data 
are consistent with data from human studies in which breast-fed infants had a higher percentage 
of PBMC NK cells than FF infants. These data suggest that NK cell population is strongly 
influenced by feeding mode. However, NK cell populations in MLN and spleen were not 
affected by diet or vaccination. 
In PBMC, the double positive (DP) memory T cell population size of LF piglets was 
smaller (p=0.0388) than those of FF piglets, with SR being intermediate, which indicates that Lf 
may play a regulatory role in immune cell activation. Diet did not affect the DP memory T cell 
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population in MLN or spleen or CD4
+
 T helper cell population, CD8
+
 cytotoxic T cell 
population, and the CD4:CD8 T cell ratio in PBMC, MLN or spleen.  
SR, FF and LF samples were pooled by tissue to evaluate cell population sizes at 
different organs. The percent of NK cell was highest (p<0.0001) in PBMC followed by the 
spleen and lowest in MLN, whereas the percent of DP memory T cell was higher (p<0.0001) in 
MLN and spleen than PBMC. Furthermore, the percent of T helper cell was higher (p<0.0001) in 
MLN compared to PBMC and spleen. However, percent of cytotoxic T cell was not different 
among different tissues. Overall, the innate defenders, NK cells, predominate in the circulation, 
while responsive DP T-cells and CD4
+
 T-cells predominate at the body’s barrier, MLN. 
NK cells isolated from PBMC were stimulated with IL-2 (20 ng/mL) or bLf (25 μg/mL) 
and incubated 48 h with K562 target cells at 10:1 effector to target cell ratio. In general, IL-2 
stimulated NK cells had higher cytotoxicity compared to bLf-stimulated or unstimulated NK 
cells. When stimulated with IL-2, NK cell cytotoxicity of LF animals was lower (p=0.0003) than 
that of SR animals with cytotoxicity of NK cells from FF piglets being intermediate. Even 
without IL-2 or bLf stimulation, NK cell cytotoxicity of LF animals was similar to FF piglets and 
significantly less (p<0.05) than SR piglets. A similar pattern was observed within the LF-
stimulated NK cells; however, the differences were not significant (p=0.0595). We also 
measured interlectin-2 (ITLN-2, LF receptor) mRNA expression in NK cells and found that LF 
piglets had 2.5-fold higher (p<0.01) ITLN-2 mRNA expression in NK cells than SR or FF 
piglets. This suggests that oral supplementation of bLf may increase LF receptor expression on 
NK cells. However, this increase in expression of LF receptors in NK cells did not increase NK 
cell’s cytotoxicity to bLf stimulation, which suggests that Lf may be involved in immune 
regulation of NK cell activation. 
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To investigate potential mechanisms for improved NK cell cytotoxicity, the mRNA 
expression of perforin, natural killer group 2 member D (NKG2D) receptors and IFN-α receptor 
in NK cells isolated from PBMCs were accessed. Perforin gene expression in NK cells from SR 
animals was 6-fold higher (p=0.0038) than FF animals and 3.5-fold higher (p=0.0038) than LF 
animals. The gene expression of perforin in NK cells from LF and FF animals was not 
significantly different. In addition, the expression of NKG2D in NK cell of SR animals was 
higher (p=0.0172) than that of FF animals, while the NKG2D gene expression in NK cell of LF 
animals was intermediate. However, the gene expression of IFN-α receptor was not affected by 
diet. The level of gene expression of perforin, NKG2D receptor, and IFN-α receptors in NK cells 
represents the activation status of NK cells.  
Overall, diet had a significant impact on NK cell population and activity. Piglets that 
were fed sow’s milk had larger NK cell population size as well as greater cytotoxic activity 
compared to those of FF. However, NK cell development was minimally affected by bLf 
supplementation. As NK cells are important first line defenders against infection, knowledge of 
factors to increase their numbers and improve their cytotoxic activity may enable us to further 
protect formula-fed infants from infection. 
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Chapter 1 
Literature Review 
The Immune System 
The immune system protects the host against foreign pathogens by a variety of effector 
cells and molecules. These immune cells have the ability to recognize foreign objects, eliminate 
harmful pathogens by their effector functions, regulate reactive response toward self-antigens 
and develop immunological memory against reinfection (Murphy et al, 2008). Classically, the 
immune system is divided into two branches, the innate and adaptive immunity. The innate 
immune system responds rapidly after exposure to an infection, whereas the adaptive immune 
system takes several days to develop (Murphy et al, 2008). Nevertheless, the adaptive immune 
response is more efficient in eliminating infections due to the specific recognition functions of 
lymphocytes that have the ability to identify the particular antigen and focus a stronger response 
on it. These two branches of the immune system work together to provide effective mechanisms 
that protect the host from damage by pathogenic organisms (Medzhitov, 1997). 
 Neonates face a dramatic transition at birth as they move from the protected sterile 
intrauterine environment to an environment full of foreign antigens (Firth et al, 2005). Due to 
limited exposure to antigens in utero, neonates initially must rely on their innate immune system 
for protection. The innate immune system influences the development of the adaptive immune 
response, thus, a distinct function of the fetal innate immunity is to avoid abortion or premature 
delivery by skew the neonates adaptive immune system towards a TH2 response (Levy, 2007). 
This bias against TH1 adaptive immunity impairs the neonate’s ability to produce pro-
inflammatory cytokines, which, in turn, alters the neonate’s effectiveness at eliminating 
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pathogens and may also increase the chance for allergy development (Levy, 2007). Therefore, 
the neonatal innate immune system plays a crucial role in both protecting the neonate from 
pathogenic infection and shaping the adaptive immune system for further protection. 
 
Innate Immune System 
 The innate defense mechanisms of the neonate consist of innate immune molecules, such 
as toll-like receptors (TLRs), acute-phase proteins, and antimicrobial proteins and peptides, as 
well as the different functional innate immune cells (Levy, 2007). Most innate immune cells 
derive from the common myeloid progenitor, each with distinct function against foreign 
antigens. Neutrophils are the most abundant leukocyte in blood and have the critical phagocytic 
function needed to control microbial infections in newborns (Firth et al, 2005). However, 
overactive phagocytosis can cause cellular damage to neonates, in particular, at the mucosal 
surface where most environmental stimuli initially interact with the host (Firth et al, 2005). 
According to Menge and colleagues (1998), neutrophil function was impaired in neonatal calves 
by the cell’s deficient ability to ingest bacteria and generate reactive oxygen species. 
Macrophages are long-living phagocytes with an additional function to process and present 
antigens to activate naïve T-cells for initiation of development of antigen-specific immunity as 
well as providing chemotactic signals to recruit other immune cells to the site of infection 
(Menge et al, 1998).  
Another immune cell type with the ability to process and present antigens is dendritic 
cells (DC). They are professional antigen presenting cells and their key function is to initiate and 
modulate the adaptive immune response (Firth et al, 2005). Plasmacytoid (PDC) dendritic cells 
are a subset of DC that can also activate innate responses. PDC are also known as type 1 
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interferon-producing cell due to their ability to secrete large amount of interferon-α and β in 
response to viral infection through TLR7 and TLR9 located in the endosomal compartments 
(Firth et al, 2005). Type 1 interferon activates NK cells, which enhances NK cell’s cytotoxic 
activity (Liu, 2005). NK cells are large granular lymphocytes that are also part of the innate 
immune system due to lack of recombination-activating gene (RAG) to generate antigen-specific 
cell surface receptors (Vivier, 2008).  
 
Natural Killer Cells 
Natural killer cells were first identified in 1975 and were classified as lymphocytes based 
on the morphology and their expression of many lymphoid markers (Vivier, 2011). Human NK 
cells express surface markers of CD56 and CD16 (Lanier and Phillips, 1992). The level of 
expression of these two cell surface markers determines the functionally of NK cells (Shi et al, 
2011). Most of the NK cells in the circulation are CD56
low
CD16
+
, which exhibit cytotoxic 
activity against target cells and have the ability to produce cytokines after encountering their 
targets (Shi et al, 2011). In comparison, the predominant NK cell subset in peripheral lymphoid 
organs is CD56
hi
CD16
-
 NK cells, which produce large amount of cytokines and acquire 
cytotoxicity upon activation (Shi et al, 2011). Therefore, CD56
hi
CD16
-
 NK cells can be 
considered “immature” NK cells; whereas CD56lowCD16+ NK cells are “mature” NK cells due to 
the fact that CD56
hi
CD16
-
 NK cells can be further differentiated into CD56
low
CD16
+
 NK (Shi et 
al, 2011). Porcine NK cells share many characteristics with human NK cells, but lack of CD56 
expression on porcine NK cells makes it difficult to identify functionally comparable NK cell 
populations in pigs. Nevertheless, porcine NK cells can be identified by distinct marker 
combinations of CD3
-
CD4
-
CD8
+
 (Gerner et al, 2009). 
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In terms of functionality, NK cells contribute to protective responses against a variety of 
infections and cancers due to their ability to lyse target cells as well as secrete inflammatory 
cytokines to further induce themselves or the neighboring immune cells (Biron et al, 1999). NK 
cells lyse infected target cells by releasing the effector protein, perforin, cytotoxic granules onto 
the surface of the bound target cell.  This mechanism of immune defense is critical for protecting 
the neonate prior to the development of cytotoxic T lymphocyte for that specific pathogen. 
Before describing the cytolytic mechanism of NK cell, its recognition of target cell will be 
introduced. 
Natural killer cell’s ability to recognize target cells and activate their cytotoxicity occurs 
through various activating receptors either independently or in combination, depending on the 
ligands on the target cells (Raulet, 2004). The NKG2D is a lectin-like type 2 transmembrane 
receptor that encodes in the gene complex of NK cell that recognize induced self-proteins 
expressed on the surface of most tumors and infected cells (Raulet, 2004). Most The NKG2D 
ligands are poorly expressed on normal cells, but are up-regulated in tumor or infected cells. In 
addition, NK cells recognize their target cells by the “missing self” signal (Lanier, 1992). 
Normal healthy cells express major histocompatibility complex (MHC) class I molecule carrying 
self-antigen on the cell surface as an identification of self-cells (Raulet, 2009). Many viral 
infections and cellular stress responses can down-regulate the expression of MHC class I 
molecule and up-regulate stress-induced self-molecules, which are recognized by NK cells as 
abnormal cells and activate the cytotoxic activity of NK cell (Lanier, 1992). The NK cells also 
express Fc receptors, which when bound to immunoglobulin will mediate antibody-dependent 
cell cytotoxicity and/or IFN-γ production (Biron et al, 1999). The effector function of NK cells is 
regulated by their stimulatory and inhibitory receptors. NK cells express MHC class I receptor 
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that belongs to the inhibitory receptor family, which signals through intracytoplasmic 
immunoreceptor tyrosine-based inhibition motifs (ITIMs) to tolerate healthy self-cells (Vivier, 
2011).  
The NK cell cytolytic mechanism is performed through intracellular granule 
rearrangement and release of cytotoxic granules upon binding to the target cell (Figure 1.1; 
Herberman et al, 1986; Roder et al, 1978).  In short, the binding of the activating receptor on the 
NK cell to the stress-induced self molecule on the target cell activates an intracellular 
rearrangement of cytotoxic granule within the NK cell toward the site of binding with the target 
cell. After the intracellular rearrangement, the cytotoxic granules are released from NK cells and 
the cytolytic effector molecules, such as perforin and granzyme B, bind to the target cell, which 
disrupts the cell membrane and activates the apoptosis mechanism within target cell. Granzyme 
B cooperates with perforin to induce target cell death.  Perforin forms pores in the target cell 
membrane via homopolymerization (Warren and Smyth, 1999), which allows passive diffusion 
of granzyme B into the cytosol of the target cell and activates the apoptosis pathway (Figure 1.2; 
Trapani and Smyth, 2002).  Granzyme B is able to cleave target cell proteins at specific aspartate 
residues to create activators for caspase-mediated and caspase-independent cell death (Trapani 
and Smyth, 2002).  
 
Adaptive Immune System 
 As mentioned earlier, the innate immune system provides immediate defense against 
pathogens, but it is not specific. In contrast, the adaptive immune system is highly specific 
toward an antigen or a pathogen and will develop immunological memory after initial exposure. 
B- and T-lymphocytes are the two major cell types in the adaptive immune system. These cells 
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are derived from a common lymphoid progenitor that can go through gene recombination to form 
antigen-specific receptors. B cells are produced and mature in the bone marrow and are activated 
in the lymph node or other peripheral lymphoid tissues; T-cells are also produced by the bone 
marrow, but they are educated and mature in the thymus (Westermann and Pabst, 1992). Similar 
to B-cells, T-cells become activated in the lymph node or other secondary lymphoid tissues. 
After antigen presentation by antigen-presenting cells in secondary lymphoid tissues, B-cells and 
T-cells are activated and generate antigen-specific B-cell receptors or T-cell receptors through 
rearrangement and somatic recombination of genes (Blom and Spit, 2006).  
Neonates are very sensitive to infections and this sensitivity may be partly due to the lack 
of pre-existing immunological memory. In addition, the quantity and quality of immune cells in 
the peripheral lymphoid tissues of newborns are also lower than those of adults (Adkins et al, 
2004). Hence, the neonatal adaptive immune system has been considered immature. 
Additionally, the neonatal immune system is biased toward a TH2 response with limited 
interleukin-2 (IL-2) and interferon-gamma (IFN-γ) production (Adkins and Du, 1998). However, 
under certain circumstances, such as vaccination, neonates are able to mount T-cell responses 
that are comparable to adult (Forsthuber et al, 1996).  
 T-cells are involved in cell-mediated immune responses, in which they enter the 
circulation and secondary lymphoid organ for clearance of pathogens and abnormal cells after 
activation through the binding of specific T-cell receptor to MHC molecules on target cells 
(Liongue et al, 2011). Starting from early pregnancy, the immune system of the mother and the 
embryo is biased toward a TH2 response in order to prevent  an immunological response against 
the fetus (Calder et al, 2006). This prenatal TH2-biased environment of the mother drives the 
formation of antigen-specific immunoglobulin E (IgE) and IgA (Bjerke et al, 1994; Shah and 
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Bapat, 2006), which are transferred to the fetus via the placental barrier into the amniotic fluid 
(Szepfalusi et al, 2000). Thus, if the neonatal immune system is not able to effectively down-
regulate the pre-existing TH2 response and overcome the presence of maternal transferred 
allergen-specific IgE antibodies, the infant may develop an allergic response. In addition to that, 
neonates need to develop an effective TH1 and inflammatory response in order to fight against 
infections. 
Plasma cells are activated B-lymphocytes that produce antibodies against pathogens. 
These antibodies are called immunoglobulins (Ig) and are also known as the secreted form of B-
cell receptor (Liongue et al, 2011). Antibodies participate in host defense in three main ways: 
neutralize bacterial toxins, opsonize bacteria in the extracellular space and activate the 
complement system to lyse bacteria in plasma (Murphy et al, 2008). There are five different 
classes of Ig, each carries special functions. IgG is the most abundant Ig in serum and main 
antibody in the secondary immune response to most antigens; IgM is the first antibody produced 
by the immune system during immune development and primary immune response; IgD acts as a 
cell surface receptor and co-expresses with IgM; IgA is the most abundant class in secretions that 
protects the mucosal membranes; IgE interacts with mast cells and basophils in generating an 
allergic response (Male, 2004). With the help from follicular helper T-cells (TFH cells), B-cells 
are able to differentiate and generate immunological memory for a second infection (Pulendran 
and Ahmed, 2011).  
Vaccination is commonly used for generating specific immunological memory toward an 
antigen. There are two broad groups of vaccines, live attenuated vaccines (LIAV) and vaccines 
that contain adjuvants.  The LIAV are a weakened version of the pathogen, which signals 
through different pathogen recognition receptors (PRRs) to activate the adaptive immune system 
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to generate specific memory cells (Pulendran and Ahmed, 2011). The purpose of adding 
adjuvant to vaccine is to stimulate the relevant immune response required for protection toward 
the specific pathogen, such as a specific TH response, cytotoxic T-cells or long-term memory T- 
or B-cells, or induce mucosal homing and persistence of antigen-specific lymphocytes 
(Pulendran and Ahmed, 2011). Children administered a LIAV influenza vaccination generated 
influenza A virus-reactive IFN-γ+ cells in T-cell and NK cell subsets (He et al, 2006).  Some 
studies also suggested that newborn mice were able to generate a TH1 response after vaccination 
(Ridge et al, 1996), which suggests that some vaccines can help in developing a TH1/TH2 
balance in neonates (Adkins and Du, 1998). 
 
Immune Development in the Neonatal Piglet 
 Compared to rodents, the piglet has been shown to be a good model for neonatal research 
for humans (Meurens et al, 2012). There are more similarities between neonatal pigs and human 
neonates in terms of anatomy, physiology, immunology and metabolism due to the fact that both 
species are omnivores (Calder et al, 2006; Puiman and Stoll, 2008). In addition, piglets can be 
reared independently from their mother and can live on bovine milk-based sow-milk replacer 
compared to other mammals (Calder et al, 2006). The gestation period in pigs is about 115 days, 
which is slightly shorter compared to humans; nevertheless, the developmental characteristics of 
nutrition and gastrointestinal (GI) tract development are similar to those of human infants at 
many points (Guilloteau et al, 2010; Puiman and Stoll, 2008). In addition, the body size of 
piglets at birth is sufficiently larger than mice, which allows extensive surgical manipulation and 
long-term dietary treatment protocols (Calder et al, 2006). Furthermore, the overall maturation of 
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the GI tract is more rapid in pigs compared to humans (Figure 1.3; Calder et al, 2006). 
Therefore, the effects of dietary treatment can be observed in a shorter experimental period.  
However, there is no maternal transfer of cells and antibodies due to the six-layered 
placenta in pigs that separates the fetus from the mother’s blood supply; thus, the piglet is highly 
dependent upon colostral intake in the first couple days of life to obtain maternal antibodies  for 
passive immunity (Rothkotter et al, 2002). Studies had shown that upon antigen uptake by the 
sow, specific antibodies are developed, and transferred to the offspring through colostrum, which 
plays an important role in the development of neonatal immune system (Telemo et al, 1991). The 
human fetus, on the other hand, receives maternal Igs through the placenta before birth (Sangild, 
2006). Nevertheless, the major populations of B-, T-, and MHC II+ cells in pigs appear to be 
similar to those in other mammals, especially the proportions of B-cell-expressed surface Igs in 
peripheral blood are similar to that in humans, with the exception of CD4+/CD8+ double 
positive T-cells (Boeker et al, 1999). The population of CD4+/CD8+ double positive T-cells in 
pigs was about 50% of the lymphocyte population in peripheral blood (Zuckermann and 
Husmann, 1996) and other organs (Zuckermann and Gaskins, 1996), whereas in humans the 
CD4+/CD8+ T-cell population was < 3% (Zuckermann, 1999).  
 
Breastfeeding  
 Neonates are highly dependent on the transfer of immune factors from their mothers via 
the placenta and/or breast-milk to gain protection against pathogens and adaptation to the world 
outside of the womb (Nguyen et al, 2007). Accumulating evidence demonstrates that 
breastfeeding can reduce the risk of developing autoimmune diseases later in life (Jackson and 
Nazar, 2006). In addition, the cellular and bioactive components found in human breast milk can 
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facilitate development of the GIT and immune system, and tolerance toward food and 
environmental antigens (Crago et al, 1979). Furthermore, NK cell populations in breast-fed 
infants were higher than in formula-fed infant (Anderson et al, 2009; Hawkes et al, 1999).  
 Secretory IgA (sIgA) in human milk supports intestinal adaptation to extrauterine life and 
prevents adhesion of luminal bacteria to the enterocytes lining the intestine (Newberg and 
Walker, 2007), which reduce the likelihood of enteric infection by E. coli and Shigella in breast-
fed infants (Reddy et al, 1977). Other components in human milk such as human-milk glycans 
and oligosaccharides also play a protective role against infections in the intestine. Cell surface 
glycans serve as the binding target of enteropathogens, which prevent the pathogens from 
binding to the mucosal surface of the intestine, thus inhibited the pathogenic invasion (Morrow, 
2005; Newburg, 2009). Nucleotides, another component of human milk, have been shown to be 
beneficial to infants as it pertains to lipid metabolism, immune development, and tissue growth, 
development and repairs (Gil, 2002).  
According to the CDC report card in 2011, 74.6% of the infants in the United States were 
breast-fed at birth, but within the first 6 months of life the rate drops to 44% (CDC, 2011).  Only 
about 35% of infants that are exclusively breast-fed for the first 3 months of life and the rate of 
breastfeeding continued to decrease after reaching 6 months of age (CDC, 2011). Because the 
rate of breastfeeding is so low, supplementation of infant formula represents an opportunity to 
provide the formula-fed neonate with similar immunological advantages to those that are breast-
fed.  
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Lactoferrin 
 Lactoferrin (Lf) is an 80 kDa iron-binding glycoprotein (Figure 1.4; Vogel et al, 2002) of 
the transferrin family found in various secretions such as breastmilk, tears, saliva, pancreatic 
juice, and degranulated neutrophils (Adlerova et al, 2008). Myeloid cells and secondary 
epithelial cells are the major cell types involved in Lf synthesis (Adlerova et al, 2008). The 
regulation of Lf synthesis is dependent on the type of cells that are producing this protein. 
Prolactin controls the amount of Lf synthesized in the mammary gland, whereas estrogen 
controls Lf production in reproductive tissues (Adlerova et al, 2008). In addition, the production 
of Lf in endometrium is influenced by epidermal growth factors (Adlerova et al, 2008). Lf is 
found predominantly in milk and colostrum.  Its concentration is higher during early lactation 
(<28 days postpartum), with approximately 4.2 g/L, which declines to about 2.1 g/L in mature 
milk (Masson and Heremans, 1971). Masson and Heremans (1971) also showed that compared 
to other species, human milk had the highest Lf concentration. The concentration of Lf in bovine 
milk and porcine milk ranges between 20 to 200 mg/L (Masson and Heremans, 1971) and in 
infant formula is about 100 mg/L (Statue-Gracia et al, 2000). 
Lf contains 703 amino acids with a protein structure of two globular lobes, N lobe and 
the C lobe, connected by a three-turn helix (Adlerova et al, 2008; Caccavo et al, 2002). Each 
lobe is comprised of two domains, and the two domains create one iron-binding site on each 
lobe; thus, there are two iron-binding sites for each Lf molecule (Adlerova et al, 2008; Caccavo 
et al, 2002). Although Lf is part of the transferrin family and they are structurally related, its 
iron-binding affinity is 300-fold higher than transferrin; thus Lf can bind to iron at low pH 
(Caccavo et al, 2002).Human Lf (hLf) shares 72.6% and 70.7% amino acid homology to porcine 
Lf (pLf) and bovine Lf (bLf), respectively (Lydon et al, 1992).  
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There are three different isoforms of Lf. Lf-α is the iron-binding form without 
ribonuclease activity, whereas Lf-β and Lf-γ contain ribonuclease activity, but are not capable of 
binding iron (Levay et al, 1995). In addition, there are three forms of Lf based on its saturation. 
ApoLf is the iron-free form; monoferric form is Lf with one ferric ion; and holoLf is the two 
ferric ion form (Adlerova et al, 2008). According to Jameson and colleagues (1998), holoLf and 
apoLf have different tertiary structures. With its high affinity for iron at low pH, Lf depletes the 
iron supply for pathogenic microbial growth at site of infection where the low pH is caused by 
the metabolic activity of bacteria (Caccavo et al, 2002). In addition to the antimicrobial 
functions, Lf is a multifunctional molecule that plays role in iron metabolism, host defense, 
tumor growth, cell proliferation and differentiation and enzymatic activity of ribonuclease A 
(Adlerova et al, 2008). 
Iron is one of the essential elements for growth of bacteria, and some pathogenic bacteria 
that highly depend on iron for growth will not survive without the presence of iron; thus, Lf is 
considered bacteriostatic with its ability to bind to free iron (Arnold et al, 1980; Brock, 1980). 
Nevertheless, some bacteria are capable of adapting to the new condition and compete with Lf 
for iron by releasing iron-chelating compounds, and some other bacteria express specific 
receptors that are capable of binding to Lf and disrupting its tertiary structure leading to 
dissociation of iron (Ekins et al, 2004; Ratledge and Dover, 2000).  
However, the bactericidal activity of Lf is not solely iron-dependent. There are receptors 
expressed on the surface of some microorganisms that are capable of binding to Lf and this 
binding can disrupt the cell wall of Gram-negative bacteria, which causes cell death (Adlerova et 
al, 2008). In addition, the positively charged surface of Lf can interact electrostatically with the 
negatively charged lipid layer of Gram-positive bacteria, which changes the permeability of the 
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membrane (Valenti and Antonini, 2005).  In addition, an antibacterial peptide (lactoferricin) can 
be derived from Lf through pepsin cleavage (Vogel, 2012). This antibacterial domain of Lf is 
found in both hLf and bLf and their relative antimicrobial efficacy was correlated (Bellamy et al, 
1992).  
Lactoferrin also plays a role in activation and suppression of the immune system. Many 
in vitro studies demonstrated that the role of Lf in modulating the activation of cells involve in 
the innate immunity, such as macrophages, neutrophils, and NK cells, or in the adaptive 
immunity, T-cells, B-cells, and DC; and the effects could be inflammatory or anti-inflammatory 
(Legrand and Mazurier, 2010). For the anti-inflammatory effect, Lf can neutralize endotoxins, 
such as LPS by binding with high affinity, which prevents it from binding to LPS binding protein 
(LBP), an acute phrase protein, to initiate an inflammatory response (Puddu et al, 2010). 
Additionally, bLf has been shown to reduce leukocyte infiltration in broncho-alveolar lavage 
fluid during influenza virus infection, which suppresses hyper-reaction of the host. Lf also 
reduces allergic airway inflammation induced by pollen antigen in a murine model of asthma by 
decreasing the recruitment of eosinophils (Griffiths et al, 2001; Yamauchi et al, 2006). For 
inflammatory response, studies have reported that Lf may activate macrophage via TLR4-
dependent or -independent signaling pathways, and Lf release from neutrophil granules can bind 
to monocytes/macrophages, which promote the secretion of inflammatory molecules (Legrand 
and Mazurier, 2010). In addition, human Lf has been shown to increase NK cell cytotoxicity in 
vitro (Damiens et al, 1998). 
Previous studies have shown that Lf receptors (LfRs) were expressed on various cell 
types, including T- and B-lymphocytes, monocytes/macrophages, platelets, liver cells, and cells 
in the GI tract (Caccavo et al, 2002). The LfR in the small intestine is called interlectin. In the 
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liver, the LfRs are identified as low density lipoprotein (LDL) receptor-related protein (LRP) and 
asialoglycoprotein receptor, and in monocytes Lf can bind to LPS receptor CD14 (Nielsen et al, 
2010). Wang and colleagues (2000) has shown that bLf orally administered to mice increased the 
number of CD4
+
 and CD8
+
 T-cells and IgM
+
 and IgA
+
 B-cells in the lamina propria of the small 
intestine. In addition, Lf increased target cell sensitivity to lysis by inducing the activation of the 
Fas signaling pathway for apoptosis (Fujita et al, 2004). Furthermore, Lf can influence cell 
proliferation and differentiation by acting as a transcription factor (Adlerova et al, 2008). The 
non-iron-binding isoform of Lf found to have ribonuclease activity that is responsible for RNA 
degradation (Adlerova et al, 2008). Moreover, studies have shown that Lf can enhance the 
efficacy of Bacille Calmette-Guérin (BCG) vaccination by generating a T-cell TH1 response 
(Hwang et al, 2005; Hwang et al, 2009). In addition, Lf increased IL-12:IL10 ratio in 
splenocytes of mice when stimulated with LPS, suggesting that Lf-LPS complex facilitate 
macrophage activation through CD14 or TLR-4 (Hwang et al, 2007).  
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Figure 1.1. NK cell cytolytic mechanism. I. NK cell recognizes its target by: 1. Down-regulation of inhibitory ligands on target cell; 
2. Up-regulation of activating ligands on target cells. II. NK cell is activated by binding to the activating ligand on target cell via its 
receptor, which activates granule rearrangement toward the target cell. III. Release of cytotoxic granule to target cell. IV. The 
cytotoxic materials in the granules activate the apoptotic pathways in target cell, which cause target cell death (Herberman et al, 
1986).     
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Figure 1.2. Cytolytic mechanism of perforin and granzyme B. Cytotoxic granules, including perforin and granzyme B, released 
from NK cells bind to the target cell, which disrupts the cell membrane and activates the apoptosis mechanism within target cell. 
Granzyme B cooperates with perforin to induce target cell death.  Perforin forms pores in the target cell membrane and granzyme B 
cleaves target cell proteins at specific aspartate residues to create activators for caspase-mediated and caspase-independent cell death  
(Reprinted by permission from Macmillan Publisher Ltd: Nature’s Review of Immunology, Trapani and Smyth, copyright 2002). 
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Figure 1.3. GI maturation in relation to birth and weaning in three different groups of mammalian species. In humans and other 
primates GIT development is slow and maturation starts early (in fetal life). In most small rodents and carnivorous species, the 
developmental changes occurs relative quickly and late (postnatally around weaning). GIT maturation in large domestic animals (pigs, 
sheep, cattle) is intermediate (i.e., maturation is rapid during the period from shortly before birth to shortly after weaning). Around 
weaning (black areas) and birth (dark grey areas), maturation is particularly rapid, resulting in a weaning cluster and a birth cluster of 
maturational changes. Birth of viable preterm neonates occurs over a wider range of gestational ages in humans compared with 
domestic animals like pigs (light grey areas) (Calder et al, 2006; Cambridge University Press; Reprinted with permission).  
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Figure 1.4. Structure of bovine lactoferrin and human lactoferrin. The portion for lactoferricin in bovine lactoferrin is highlighted 
in green, and the portion for lactoferricin in human lactoferrin is highlighted in yellow (©2008 Canadian Science Publishing. 
Reproduced with permission, Vogel et al, 2002).
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Chapter 2 
Research Objective, Hypothesis and Specific Aims 
 
 The neonatal innate immune system is important in both protecting the neonate from 
pathogenic infection and shaping the adaptive immune system for further protection.  NK cells 
are large granular lymphocytes that contribute to protection against a variety of infections due to 
their ability to kill target cells as well as secrete inflammatory cytokines to further induce 
themselves or the neighboring immune cells to mount a protective response (Biron et al, 1999). 
They are part of the innate immune system due to the lack of recombination-activating gene 
(RAG) needed to generate antigen-specific cell surface receptors (Vivier, 2008). Therefore, the 
NK cell population is crucial in protecting the neonate prior to the development of cytotoxic T-
lymphocytes for that specific pathogen.  
Lactoferrin, an iron-binding glycoprotein found in human milk, has many immune-
modulating effects (Adlerova et al, 2008).  It has high iron-binding affinity, which allows iron-
binding at low pH to deplete iron supply for pathogenic bacterial growth (Arnold et al, 1980; 
Brock, 1980; Caccavo et al, 2002).  Ex vivo stimulation with hLf has also been shown to increase 
human NK cell cytotoxicity (Damiens et al, 1998). Additionally, oral administration of bovine Lf 
(bLf) in adult mice was able to enhance NK cell cytotoxicity in vivo (Kuhara et al, 2006).  These 
studies investigated the effect of Lf on NK cell cytotoxicity in adult animals. However, the effect 
of Lf on NK cell development in young animals has not been investigated. The piglet has been 
shown to be a good model for neonatal research for human compared to rodents due to the 
similarities they shared in terms of anatomy, physiology, immunology and metabolism (Calder et 
al, 2006; Puiman and Stoll, 2008; Meurens et al, 2012).  Therefore, we used the piglet model to 
study how bLf influences NK cell development in the neonate.  
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 The overall goal of this thesis research was to investigate the interaction between dietary 
bLf and vaccination on T-cell and NK cell populations as well as NK cell cytotoxic activity in 
neonatal piglets. The overall hypothesis of this research was that dietary bLF would influence T-
cell subpopulations and NK cell development compared to piglets fed unsupplemented formula. 
In addition, we hypothesized that bLf-fed (LF) piglets would exhibit a T-cell and NK cell 
population as well as NK cell cytotoxicity more similar to sow-reared (SR) piglets than FF. 
Lastly, we hypothesized that piglets vaccinated with Fluzone would produce more double 
positive memory T-cells than the non-vaccinated pigs. To test these hypotheses, two specific 
aims were conducted.  
Specific Aim 1 investigated the T-cell and NK cell populations in the blood, spleen and 
mesenteric lymph nodes (MLN) of piglets fed formula with 1 g/L bLF (LF), fed formula alone 
(FF) and sow-reared (SR) piglets with or without Fluzone vaccination.  
The working hypothesis was that LF piglets would exhibit T-cell and NK cell 
percentages that were more similar to SR piglets and greater than their FF counterparts. In 
addition, vaccination would increase the percentage of double positive (DP) memory T-cells. 
This hypothesis would be manifested through greater CD8
+
 cytotoxic T-lymphocytes, DP 
memory T-cells and NK cell populations in SR and LF animals than in FF animals. 
Specific Aim 2 examined NK cell cytotoxic activity in NK cells isolated from PBMCs of 
animals fed the three diets. The working hypothesis of this aim was that LF piglets would exhibit 
NK cell cytotoxicity more similar to SR piglets, which would be greater than that of FF piglets. 
This hypothesis would be manifested through higher NK cell cytotoxic activity, higher mRNA 
expression of perforin, NKG2D receptors and IFN-α receptors in NK cells of SR and LF piglets 
than FF piglets. 
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Chapter 3 
Experimental Approach  
Materials and Methods 
Chemicals 
 All chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless indicated 
otherwise. 
 
Dietary Bovine Lactoferrin 
 Bovine lactoferrin (bLF) was provided by Mead Johnson Nutrition (Evansville, IN), 
which obtained it from DMV International (FrieslandCampina, Netherlands). The bLF was in 
powder form with 98% purity and 120 mg/kg of iron, which is about 11.9% saturation if all iron 
was bound by bLF. The bLf was reconstituted in double distilled, deionized water to a 
concentration of 100 g/L. During formula preparation for LF animals, 10 mL of the 100g/L of 
bLF solution was added to 1L of formula for a final concentration of 1g bLf/L formula.  
 
Dietary Treatments and Animal Protocol 
 All animal care and experimental procedures were in accordance with the National 
Research Council Guide for the Care and Use of Laboratory Animals and were approved by the 
Institutional Animal Care and Use Committee at the University of Illinois. Pregnant sows were 
purchased from Midwest Research Swine (Gibson, MN), and transported to the animal facilities 
within the Edward R. Madigan Building (ERML). Upon arrival, sows were vaccinated with 
LitterGuard LT-C (Pfizer Animal Health, Exton PA), Respisure (Pfizer Animal Health), and 
BPE (Intervet Inc., Millsboro, DE) and placed on gestation diet enriched with antibiotic (BMD, 
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Montréal, Québec, Canada). Sows received a booster vaccination 2 weeks prior to farrowing. 
Sows were monitored for farrowing. Piglets were born by vaginal delivery and received 4 hours 
of colostrum from the sow before randomization to the diet groups. Piglets in the formula group 
(FF) were fed a non-medicated sow milk replacer formula (Advance Baby Pig Liquiwean, Milk 
Specialties Global Animal Nutrition, Carpentersville, IL) 22-times daily at a rate of 360 mL/kg 
BW/d. Piglets in the lactoferrin (LF) group received the same formula at the same rate with 
supplementation of 1g bLf/L formula. The remaining piglets remained with the sow throughout 
the study (SR).  
Piglets in each diet group were further randomized to be vaccinated (V) or non-
vaccinated (NV). Vaccinated animals received a pediatric dose (0.25 mL) of Fluzone™ (Sanofi 
Pasteur, Swiftwater, PA) vaccine by intramuscular injection at postnatal d7 followed by a 
booster on d14. Blood samples of all animals were collected at both time points by jugular 
puncture and serum obtained by centrifugation. FF and LF piglets were individually-housed in 
environmentally-controlled rooms (25
o
C) in specially designed cages, which are capable of 
maintaining three piglets separated by Plexiglas partitions. The study was conducted in three 
replicates (August, October, and December 2011).  
 
Sample Collection 
 On d21 postpartum, piglets were sedated with intramuscular injection of Telazol (7 
mg/kg body weight, Fort Dodge Animal Health, Fort Dodge, IA) and blood was collected 
through intracardiac puncture into non-coated vacuum tubes (BD Biosciences, Franklin Lakes, 
NJ) for serum isolation or heparin-containing vacuum tubes (BD Biosciences). Piglets were then 
euthanized by an intracardiac injection of sodium pentobarbital (72 mg/kg BW, Fatal Plus, 
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Vortech Pharmaceuticals, Dearborn, MI). After euthanasia, the small intestine was removed and 
separated from the pyloric sphincter and ileocecal valve. The small intestine was then measured 
for the total length and cut at 10% and 85% from the proximal end to give 3 segments 
corresponding to the duodenum, jejunum, and ileum, respectively. Each section was rinsed with 
cold PBS and weighed. Spleen and mesenteric lymph node (MLN) samples were also collected 
for total cell isolation as described below. 
 
Peripheral Blood Mononuclear Cell (PBMC) Isolation 
 Peripheral blood was drawn into heparin-containing vacuum tubes, diluted 2:1 with 
RPMI-1640 (Invitrogen Gibco, Grand Island, NY), layered onto Ficoll-Paque Plus (GE 
Healthcare, Piscataway, NJ), and spun at 400xg for 40 min at 20
o
C. PBMCs were collected from 
the gradient interface (Figure 3.1). Red blood cells were lysed using lysis buffer (0.15M NH4Cl, 
10mM KHCO3, and 0.1mM Na2EDTA). PBMCs were then washed three times in wash buffer 
(HBSS; Hanks Buffered Salt Solution, no Ca
++
, no Mg
++
 [Gibco, Grand Island, NY] 
supplemented with 2% BSA, 0.01M EDTA, 50 μg/mL Gentamycin [Invitrogen Gibco] and 1000 
U/mL Penicillin and 100 μg/mL Streptomycin [Invitrogen Gibco]). PBMCs were suspended in 
complete RPMI-1640 supplemented with 10% FBS, 2mM Glutamine, 50 μg/mL Gentamycin, 
1mM Sodium Pyruvate (Invitrogen Gibco), 20mM HEPES (Invitrogen Gibco), and 20mM 
Penicillin/Streptomycin. The number of viable cells was assessed by counting after staining with 
trypan blue (Invitrogen Gibco). Cells were then phenotyped and quantified by flow cytometry or 
used for NK cell isolation as described below.  
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Total Cell Isolation from Spleen and MLN 
 Spleen and MLN samples were collected with HBSS buffer described for PBMC (Figure 
3.1). The washed tissues were then placed in C-tubes (Miltenyi Biotech, Auburn, CA) with 10 
mL HBSS and chopped using Gentle MACS (Miltenyi Biotech). The resulting cell solutions 
were strained through a 100 µm (BD Falcon, San Jose, CA) followed by a 40 µm cell strainer 
(BD Falcon). After lysing the red blood cells, the isolated cells were washed three times in wash 
buffer and suspended in complete RPMI-1640. The number of viable cells was assessed by 
counting after staining with trypan blue.  Cells were phenotyped by flow cytometry as described 
below. 
 
Isolation of NK Cells and Phenotypic Identification for Purity 
 NK cells were prepared from the PBMCs by negative selection with magnetic-assisted 
cell separation (Figure 3.2).  Briefly, an antibody cocktail containing mouse IgG1 anti-pig 
CD172a (clone 74-22-15, Southern Biotech, Birmingham, AL), anti-pig CD21 (clone BB6-
11C9.6, Southern Biotech), and anti-pig CD3 (clone PPT3, Southern Biotech) was prepared and 
mixed with 1x10
6
 cells/mL. Samples were incubated on ice for 30 min. After centrifugation, 
cells were washed with autoMACS
TM
 rinsing solution/10% BSA (Miltenyi Biotec). Then, the 
cells were incubated with anti-mouse IgG1 MicroBeads (Miltenyi Biotec) on ice for 15 min and 
applied to LD columns (Miltenyi Biotec). Undesired cells (CD3
+
CD21
+
CD172a
+
) were labeled 
with the antibodies and subsequently the magnetic microbeads, which attached to the column. 
The desired cells (CD3
-
CD21
-
CD172a
-
) flowed through the column and were collected in 15mL 
conical tubes. The flow through cells were stained with anti-CD3:PECy5 (Southern Biotech), 
anti-CD21:PE (Southern Biotech), and anti-CD172a:FITC (Southern Biotech) to determine the 
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effectiveness of isolation (Figure 3.3). These cells were also stained with NK cell markers, anti-
CD3:PECy5, anti-CD4:FITC (clone 74-12-4, Southern Biotech), and anti-CD8:PE (clone 76-2-
11, Southern Biotech) to determine the percent of flow through cells that were NK cells (Figure 
3.4). The flow through cell population was 92.5% ± 5.8% CD3
-
CD21
-
CD172a
-
 and 80.7% ± 
13.4% CD3
-
CD4
-
CD8
+
 (NK cells). Flow staining is described below. Additionally, a cytospin 
was done to evaluate the morphology of the isolated cells (Figure 3.5). Isolated NK cells were 
resuspended in complete RPMI at 1500 cells/μl and then stained with methylene blue derivatives 
and eosin at the University of Illinois Veterinary Diagnostic Laboratory. Slides were scanned in 
the Institute of Genomic Biology at the University of Illinois using the Apotome Fluorescent 
Microscopy (Carl Ziess LLC Microscopy, Thornwood, NY). The enriched NK cell fraction was 
used in the cytotoxicity assay described next.  
 
Natural Killer Cell Cytotoxicity Assay by Flow Cytometry 
 A flow cytometry-based assay (Toka et al, 2009) was used to determine the lytic activity 
of NK cells. Briefly, K562 tumor cells, a human erythroleukemia cell line (ATCC, CCL-243, 
Manassas, VA), were used as the target cells (Appendix A). The K562 cells were pre-labeled 
with DiOC18 (Invitrogen Gibco), a lipophilic carbocyanine membrane dye for identification of 
total target cells. Ten microliter of DiOC18 stock solution was added to each 1.0×10
6
 cell/mL of 
PBS and incubated for 20 min at 37
o
C. The cells were then washed twice with PBS and 
resuspended in complete RPMI. Meanwhile, 1×10
5
 effector cells (NK cells) were placed in 
round-bottom 96 well plates and pre-stimulated with 10 μl of 25 μg/mL of bLf or 20 ng/mL of 
IL-2 (recombinant Human IL-2, Invitrogen Gibco) for 2 h at 37
o
C, after which DiOC18 pre-
labeled target cells were added at a 10:1 effector: target cell ratio and further incubated for 48 h 
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at 37
o
C. Propidium iodide (Invitrogen Gibco) was then added to the cell mixture and incubated 
for 30 min at 37
o
C to identify killed cells. Immediately after incubation, cytotoxicity was 
measured by flow cytometry version 7.0 (BD
 
Biosciences). The relative percentage of live and 
dead target cells was determined using FlowJo version 7.0 software (FlowJo; Ashland, OR). 
Cytotoxicity was reported as killed target (PI
+
DiOC18
+
, R1) cells as a percent of total target 
(DiOC18
+
, R2) cells using spontaneous target cell death as a normalizer. Percent cytotoxicity 
was calculated by the formula (R1/R2 in the test – R1/R2 of spontaneous cell death) × 100. 
Spontaneous target cell death was determined by incubation of DiOC18 labeled K562 target cells 
in cell culture medium alone, followed by PI-staining after harvest. 
 
Phenotypic Identification of Mononuclear Cells from Blood and Total Cells from MLN and 
Spleen 
 The phenotypes of lymphocyte subpopulations from peripheral blood, MLN, and spleen 
were monitored by flow cytometry using a panel of fluorescently labeled monoclonal antibodies 
(mAbs). T-lymphocytes were identified by mouse anti-pig CD3:PECy5 (Southern Biotech). To 
further identify the T-cell populations, mouse anti-pig CD4:FITC (Southern Biotech) and mouse 
anti-pig CD8:PE (Southern Biotech) were used to stain the cells. All staining procedures took 
place on ice and extra care was taken to prevent unnecessary light exposure. Briefly, one million 
cells per well were blocked with a mixture of 5 µg/mL unlabeled anti-CD 16 (Clone G7, AbD 
Serotec, Raleigh, NC) and 5% mouse serum (Southern Biotech) to prevent non-specific binding 
of antibodies to cells. Anti-CD3, -CD4, and -CD8 antibodies were added to the wells, incubated 
for 15 min, centrifuged, and then aspirated the supernatant. Cells were washed twice with 
staining buffer (PBS, no Ca
++
, no Mg
++
 [Invitrogen Gibco], 0.1% sodium azide, and 1% BSA), 
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and then fixed with 2% paraformaldehyde. Staining was assessed using an LSRII flow cytometer 
(BD
TM
, Biosciences). The relative percentage of T-lymphocyte subpopulations was determined 
using FlowJo 7.0 software. CD3
+
 events were considered T-cells. CD3
+
CD4
+
CD8
-
 events were 
considered T helper cells. CD3
+
CD4
+
CD8
+
 events were considered double positive memory T 
cells. CD3
+
CD4
-
CD8
+
 events were considered cytotoxic T-cells. Helper T-, memory T- and 
cytotoxic T-cell populations are expressed as a percent of CD3
+
 events (Figure 3.6). Lastly, NK 
cells were identified as CD3
-
CD4
-
CD8
+
 events (Gerner et al, 2009). NK cell populations are 
expressed as a percent of CD3
-
 events. 
 
NK cell Gene Expression 
 Total RNA was extracted and purified from NK cells isolated from PBMC with the 
TRIzol reagent (Invitrogen, Grand Island, NY) following the manufacturer’s protocol. RNA was 
quantified by spectrophotometry using a Nanodrop 1000 (Thermo Scientific, Rockford, IL) at 
260nm. Ten million NK cells were used for the extraction and yielded approximately 800-1000 
ng/μL of RNA. RNA concentration was adjusted to 0.25 μg/mL using RNase free water 
(Invitrogen) and RNA quality was analyzed using a Bioanalyzer (model 2100, Agilent 
Technologies, Inc., Santa Clara, CA) in the W. M. Keck Center, at the University of Illinois. All 
samples had an RNA integrity number (RIN) greater than 6.0. 
 Reverse transcription (RT) was performed using an Eppendorf Thermal Cycler (Fisher 
Scientific, Pittsburgh, PA). Each reaction contained 3 μg of total RNA and 10 μL of mixture 
from High Capacity cDNA Reverse Transcription Kit (Applied Biosystems Inc., Foster City, 
CA) involving 100mM deoxyribonucleotide triphosphate (dNTP), 10X RT Buffer, 10X RT 
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Random Primers, MultiScribe Reverse Transcriptase, RNAse inhibitor and Diethylporycarbonate 
(DEPC)-treated water (Invitrogen) for a final volume of 20 μL.  
Quantitative real-time PCR was conducted using Taqman PCR expression arrays 
(Applied Biosystems Inc.) and fluorescence intensity was detected using Taqman ABI 7900 
machine (Applied Biosystems Inc.). Samples were submitted to a total of 40 amplification cycles 
per run. The primers used are listed in Table 3.1. Peptidylprolyl isomerase A was used as a 
reference gene (Toka et al, 2009). Results were expressed using the Relative Standard curve 
method. Briefly, serial dilutions from a stock of pooled porcine NK cell cDNA ranged from 1:5 
to 1:15,625 were made and run on each plate. Each sample was run in triplicate. A normalized 
value for each target was calculated by dividing the mean target expression by the mean 
Peptidlyprolyl isomerase A quantity expression. A fold-difference was calculated for each 
measurement by dividing the normalized target values by the normalized calibrator sample (in 
this case the average of FF group). All samples that were tested for statistical differences were 
run on the same plate. 
 
Statistical Analysis 
 Intestinal weight and length, T-cell subpopulation, NK cell cytotoxicity and gene 
expression data were analyzed using the GLM model within SAS (Version 9.2, SAS Institute 
Inc., Cary, NC). The model for intestinal weight and length included diet as the major factor. The 
model for T cell subpopulation analysis contained the effects of diet, vaccination, and 
diet*vaccination interactions. If the model was significant and vaccination was not significant 
but there was a trend for diet to be significant, data from vaccinated and non-vaccinated piglets 
were combined. The model for NK cell cytotoxicity analysis contained the effect of diet, 
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treatment, and diet*vaccination interactions. The model for gene expression included diet as the 
major factor. Data of daily weight gain of the piglets was analyzed as Chi-squared test using the 
PROC MIXED procedure within SAS. The normality of the data was confirmed by the normality 
test within SAS and a Shapiro-Wilk number greater than 0.8 indicated that the data were 
normally distributed. Data are reported as mean ± SD. Comparisons with p<0.05 were 
considered significant and comparisons with p<0.10 were considered trends. 
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Figure 3.1. Method for isolation of peripheral blood mononuclear cells and total cells from spleen and MLN of piglets on d21.  
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Figure 3.2. Magnetic-assisted cell separation method. PBMCs were isolated from the blood of 19-day-old sow-reared piglets (n=4). 
The PBMC population was incubated with 1 µg/1 ×10
6
 cells/mL anti-CD3, 2 µg/1 ×10
6
 cells/mL anti-CD21, and 2 µg/1 ×10
6
 cells/mL 
anti-CD172a antibodies to label T-cells, B-cells and granulocytes, respectively.  The cell mixture was then magnetically-labeled with 
MACS microbeads. The cell mixture was applied to the column. During magnetic separation, the T-cells, B-cells and granulocytes 
were retained on the MACS column. The DCs passed through the column and were collected as the enriched unlabeled fraction. 
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Figure 3.3. Flow cytometry: Effectiveness of the NK isolation. Isolated cells were stained with anti-CD3, -CD21, and –CD172a to 
access the effectiveness of the isolation. 
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Figure 3.4. Flow cytometry: NK cell purity. The isolated cells were stained with anti-CD3, -CD4, and –CD8 antibodies to determine 
the NK cell population within the isolated cells. 
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Figure 3.5. Histomorphology: Methylene blue derivatives and eosin stained NK cells.  
Large Granular Lymphocyte (NK cell) Isolated NK cells from PBMC of 21-day old piglets 
 
(Male, 2004)  
 
Isolated NK cells from PBMC 
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Figure 3.6. Flow cytometry gating procedure for NK cell population and T-cell subpopulations. The lymphocyte population was 
selected on the side scatter vs forward scatter plot. The T cell subpopulations were identified from the CD3
+
 population and the NK 
cell population was identified from the CD3
-
 population. 
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Table 3.1. TaqMan gene expression assays for quantitative real-time PCR. 
 
 
Gene TaqMan Gene Expression Assay
1
 
IFN-α receptor 1 Ss03381352_u1 
Interlectin-2 (LF receptor) Ss03374218_m1 
KLRK1 (NKG2D) Ss03392377_m1 
Peptidylprolyl isomerase A
2
 Ss03394782_g1 
Perforin Ss03373694_m1 
1 
Applied Biosystems, Foster City, CA
 
2 
Reference gene 
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Chapter 4 
Results 
Formula Intake and Body Weight Gain 
 Formula intake was similar among the two diets; averaging 1076 ± 189 and 1088 ± 178 
mL/day for the FF and LF piglets, respectively, over the 21-day study period. Average daily 
body weight of SR, FF, and LF piglets is shown in Figure 4.1. Average body weight of piglets at 
birth was 1.42 ± 0.33 kg, which was not different between diet groups. Beginning on d3, SR 
animals weighed an average of 2.08 ± 0.51 kg, which was higher (p<0.05) than FF (1.57 ± 0.35 
kg) or LF (1.63 ± 0.34 kg) animals. Up to d21 of the study period, SR animals maintained a 
higher (p<0.0001) body weight than FF or LF animals. On d21, SR pigs weighed 7.52 ± 1.31 kg 
compared to FF (5.45 ± 1.20 kg) and LF (5.97 ± 0.83 kg) animals. In addition, average body 
weight of LF animals on d21 was significantly different (p=0.0113) than that of FF animals. 
Daily body weight gain, averaged by week, was greater (p<0.001) in SR than FF or LF in the 
first two weeks of the study period (Figure 4.2). SR animals gained an average of 0.22 ± 0.07 kg 
of body weight in the first week and gained 0.30 ± 0.20 kg/d in the second week, whereas both 
FF and LF animals gained an average of 0.12 ± 0.3 kg/d in the first week and 0.2 ± 0.5 kg/d in 
the second week.  During the third week of the study, daily weight changes of LF animals was 
0.33 ± 0.056 kg, which was similar to SR animals (0.34 ± 0.06 kg/d), but greater than those of 
FF animals who continued to gain less weight (0.28 ± 0.056 kg/d) compared to SR animals 
(p<0.01).  
 
 
 
38 
 
Intestinal Weight and Length 
 Absolute intestinal length (cm), absolute intestinal weight (g), intestinal length 
normalized by body weight (cm/kg), intestinal weight normalized by body weight (g/kg), and 
intestinal weight normalized by intestinal length (g/cm) are shown in Table 4.1. Absolute 
intestinal length and weight between the three diet groups were not different. However, after 
normalization with body weight, the intestinal weight of SR animals was lower (p<0.0001) than 
that of FF or LF animals. Similarly, after normalization with body weight, intestinal length of SR 
animals was less (p<0.0001) than that of FF or LF animals. When normalized by intestinal 
length, intestinal weight was highest in LF (0.30 ± 0.04 g/cm) and lowest in SR (0.27 ± 0.03 
g/cm) animals, with FF animals (0.28 ± 0.04 g/cm) intermediate between the two diet groups 
(p=0.0201). 
 
NK cell and T cell populations 
 Flow cytometry was used to analyze NK cell and T-cell populations in PBMC, MLN, and 
spleen. NK cell populations were presented as percent of the CD3
-
 population and the T-cell 
populations are presented as percent of the CD3
+
 population.  Diet did not affect NK cell 
population size in PBMC between the vaccinated animals (Figure 4.3). The NK cell population 
size of SR vaccinated animals (SRV) was 18.8 ± 12.1%, which was not different than FF 
vaccinated (FFV, 20.8  ± 10.58%) and LF vaccinated (LFV, 13.3 ± 4.89%) animals. In contrast 
to the vaccinated animals, among non-vaccinated animals, diet had a significant effect on NK 
cell population size. SR non-vaccinated (SRN, 20.7 ± 13.4%) animals had over twice (p<0.05) as 
many NK cells than non-vaccinated FF (FFN, 8.94 ± 2.96%), whereas the percent of NK cell in 
non-vaccinated LF (LFN, 11.7 ± 4.97%) was not significantly different from either SRN or FFN. 
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In addition, the NK cell population size of FFV animals (20.8 ± 10.6%) was significantly larger 
than those of FFN. NK cell population sizes in MLN and spleen were not affected by diet or 
vaccination (Figure 4.4).  
 When overall T-cell populations were examined, it was found that vaccination did not 
affect T-cell population sizes in the animals fed any of the diets; thus vaccination data were 
pooled in each diet group. Diet did not affect the CD4
+
 T helper cell population sizes, CD8
+
 
cytotoxic T cell population sizes or the CD4:CD8 T cell ratio in PBMC, MLN, or spleen (Table 
4.2, Figure 4.5). However, in PBMC, the percent of double positive (DP) memory T cell of FF 
piglets (11.9 ± 4.70%) was higher (p=0.0388) than those of LF piglets (7.86 ± 2.53%), with SR 
(10.9 ± 6.75%) being intermediate (Figure 4.6 A). However, diet did not affect the DP memory 
T cell population sizes in MLN (Figure 4.6 B) or spleen (Figure 4.6 C).  
T-cell data from SR, FF and LF samples were pooled by tissue to evaluate cell population 
sizes at different organ sites. PBMC exhibited the highest (p<0.0001) percentage of NK cells, 
with an average of 15.9 ± 10.1% followed by the spleen with an average of 8.9 ± 5.49% and then 
MLN (5.61 ± 3.2%) (Figure 4.7). T-cell subpopulation sizes were also compared among PBMC, 
MLN and spleen (Figure 4.8). The percent of DP memory T-cell was higher (p<0.0001) in MLN 
(16.1 ± 5.85%) and spleen (13.9 ± 5.19%) than PBMC (10.2 ± 5.25%) (Figure 4.8 B). 
Furthermore, the percent of helper T-cell was higher (p<0.0001) in MLN (57.9 ± 15.7%) 
compared to PBMC and spleen with an average of 40.3 ± 10.2% and 36.9 ± 9.5% (Figure 4.8 
A). However, the percent of cytotoxic T-cell was not different among different tissues (Figure 
4.8 C).  
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NK Cell Cytotoxicity 
 NK cells isolated from PBMC were used for this assay. Vaccination did not affect the 
cytotoxic activity of NK cell thus data from vaccinated and non-vaccinated animals was pooled. 
In general, IL-2 stimulated NK cell activity in all diet groups with an average of 26.2 ± 12.8%, 
which was higher (p<0.0001) than the cytotoxic activity of LF-stimulated (12.6 ± 13.8%) and 
unstimulated (13.2 ± 15.1%) NK cells (Figure 4.9). When stimulated with IL-2, NK cells 
isolated from SR animals (40.5 ± 13.7%) exhibited greater (p=0.0003) cytotoxicity compared to 
those isolated from LF (13.8 ±13.0%) animals. NK cell cytotoxicity of cells isolated from FF 
animals (24.2 ± 11.8%) was not different from those isolated from SR or LF animals. Even 
without stimulation, NK cells from SR animals were more effective at killing target cells (25.1 ± 
20.8%; p=0.0429) than those from LF (6.52 ± 11.6%) or FF (8.06 ± 13.0%) animals. A trend 
(p=0.0595) for a similar pattern was observed within the LF-stimulated NK cells; however, the 
differences did not reach the level of statistical significance. 
 
NK Cell Gene Expression 
 The mRNA abundance of several genes was measured in NK cells. Expression of 
interlectin-2 in NK cells from LF animals was 2.5-fold higher (p=0.0095) than FF and SR 
animals (Figure 4.10). Perforin expression (Figure 4.11) in NK cells from SR animals was 
higher (p=0.0038) than FF or LF animals. Expression of perforin in NK cells from LF animals 
was 2-fold higher than FF; however the difference was not significant (p=0.0633). In addition, 
the expression of NKG2D in NK cells of SR animals was higher (p=0.0172) than that of FF 
animals, while the NKG2D gene expression in NK cells of LF animals was intermediate (Figure 
4.12). However, the gene expression of IFN-α receptor was not affected by diet (Figure 4.13). 
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Figure 4.1. Body weight gain of piglets. Daily body weight was recorded for each piglet throughout the 21 day study period. No 
vaccination difference was detected thus data within a diet groups were pooled. Data are expressed as mean ± SD. * represents 
significant differences (p<0.05). On d3 through 20, SR pigs weighed significantly more than FF or LF pigs, but body weights of FF 
and LF did not differ. On d21, LF pigs weighed significantly more (p=0.0113) than FF pigs. The weight of SR pigs on d21 was greater 
than FF and LF pigs. 
 
42 
 
Figure 4.2. Incremental weight gain averaged by week. Daily body weight was recorded for each piglet throughout the 21 day 
study period. No vaccination difference was detected thus data within a diet group was pooled. Incremental weight gain was 
calculated using daily body weight change of the animals in each diet group. Data are expressed as mean ± SD. Different letter 
superscripts indicate significant difference at p<0.05. Throughout the entire study, SR pigs gained more weight (p<0.0001) than FF 
pigs each day. However, SR pigs only gained more weight than LF pigs each day during the first two weeks of the study. SR and LF 
pigs gained a similar amount of weight each day during week 3. 
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Table 4.1. Intestinal weight and length of piglets on d21. Intestinal length was normalized by body weight (cm/kg) and intestinal 
weight was normalized by body weight (g/kg) and intestinal length (g/cm). Data are expressed as mean ± SD. Means within a row 
without a common letter differ. Absolute intestinal length (cm) and weight (g) were not different among the diet groups. Intestine 
weight normalized by body weight (g/kg) was significantly lower in SR, whereas FF and LF animals were similar. Similarly, intestine 
length normalized by body weight (cm/kg) was significantly shorter in SR compared to FF and LF, but no significant difference was 
observed between FF and LF piglets. Intestine weight normalized by length was lower in SR than LF animals, however the intestinal 
weight for length in FF animals was not significantly different compared to that seen in either SR or LF animals. 
 
 
 
SR (n=24) FF (n=22) LF (n=21) Model p value 
Total intestinal length (cm) 842.7 ± 103.6 825.5 ± 86.5 831.9 ± 73.4 0.8033 
Total intestinal weight (g) 225.4 ± 43.4 233.4 ± 47.6 248.9 ± 38.7 0.1947 
Intestinal length/BW (cm/kg) 114.1 ± 17.0
b
 153.2 ± 27.9
a
 141.2 ± 17.8
a
 <0.0001 
Intestinal weight/BW (g/kg) 30.23 ± 5.0
b
 42.5 ± 6.1
a
 42.0 ± 6.24
a
 <0.0001 
Intestinal weight/length (g/cm) 0.27 ± 0.03
b
 0.28 ± 0.04
ab
 0.30 ± 0.04
a
 0.0201 
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Figure 4.3. PBMC NK cell populations of piglets on d21. PBMCs were isolated and stained with a panel of fluorescently-labeled 
mAbs targeting CD3, CD4, and CD8 and separated by flow cytometry. Data are presented as % of CD3
-
 lymphocyte population and 
expressed as mean ± SD. Different letter superscripts indicate significant differences at p<0.05.  In vaccinated (V) animals, NK cell 
populations were similar among the diet groups. However, in non-vaccinated (NV) animals, SR animals exhibited a significantly 
larger NK cell population than FFN animals, whereas the NK cell population in LFV animals did not differ from those in SRN or LFN 
animals. Furthermore, FFV animals had larger proportion of NK cells than FFN animal. 
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Figure 4.4. Neither diet nor vaccination affected NK cell populations in MLN and spleen of piglets at d21. NK cells were 
isolated from MLN and spleen from 21-day-old piglets and stained with a panel of fluorescently label mAbs targeting CD3, CD4, and 
CD8 and separated by flow cytometry. Data are presented as % of CD3
-
 lymphocyte population and expressed as mean ± SD. A) The 
proportion of NK cells in MLN was unaffected by diet or vaccination B) The proportion of NK cells in spleen was unaffected by diet 
or vaccination. 
 
 
 
 
A)         B)
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Table 4.2. CD4
+
 and CD8
+
 T-cell populations of piglets were similar among treatment groups on d21. Cells were isolated from 
blood, MLN, and spleen and stained with a panel of fluorescently-labeled mAbs targeting CD3, CD4, and CD8 and separated by flow 
cytometry. The data are presented as % of CD3
+
 lymphocyte population and expressed as mean ± SD. No vaccination difference was 
detected thus data from vaccinated and non-vaccinated piglets were pooled. CD4
+
 and CD8
+
 T-cell populations in PBMC, MLN, and 
spleen were not different between diet groups.  
 
 
 
 
 PBMC MLN Spleen 
 CD4
+
 CD8
+
 CD4
+
 CD8
+
 CD4
+
 CD8
+
 
SRN 42.7 ± 8.36 20.8 ± 3.38 55.9 ± 5.47 18.36 ± 4.32 34.92 ± 15.39 26.27 ± 10.08 
SRV 41.3 ± 9.38 21.3 ± 5.63 57.1 ± 6.98 18.30 ± 6.20 40.56 ± 19.24 22.62 ± 13.23 
 
FFN 
42.0 ± 10.6 19.8 ± 6.29 60.5 ± 5.58 16.05 ±2.64 40.16 ± 14.89 15.48 ± 9.24 
FFV 40.9 ± 7.06 20.9 ± 4.40 51.5 ± 19.7 20.23 ± 11.77 39.53 ± 15.16 16.68 ± 10.27 
 
LFN 
37.5 ± 13.0 19.8 ± 3.72 61.1 ± 3.97 17.07 ± 2.90 32.07 ± 17.23 21.85 ± 14.03 
LFV 36.9 ± 12.9 20.5 ± 4.24 62.0 ± 5.30 17.14 ± 3.15 33.40 ± 13.03 22.80 ± 11.76 
 
Model p 
value 
p=0.6958 p=0.9715 p=0.2761 p=0.6489 p=0.7323 p=0.2442 
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Figure 4.5. CD4:CD8 T-cell ratio  of piglets was similar among treatment groups on d21. Cells were isolated from blood, MLN, 
and spleen and stained with a panel of fluorescently-labeled mAbs targeting CD3, CD4, and CD8 and separated by flow cytometry. 
No vaccination difference was detected thus data from vaccinated and non-vaccinated piglets were pooled. The data are presented as 
% of CD4
+
 lymphocytes/% of CD8
+
 lymphocytes and expressed as mean ± SD. A) CD4:CD8 T cell ratio in PBMC was not different 
between diet groups. Similar results were seen in MLN (B) and spleen (C).  
 
 
 
 
A)       B)        C) 
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Figure 4.6. Double positive (DP) memory T-cell population in PBMC, MLN and spleen of piglets on d21. Cells were isolated 
from blood, MLN, and spleen and stained with a panel of fluorescently-labeled mAbs targeting CD3, CD4, and CD8 and separated by 
flow cytometry. No vaccination difference was detected thus data from vaccinated and non-vaccinated piglets were pooled. The data 
are presented as % of CD3
+
 lymphocyte population and expressed as mean ± SD. Different letter superscripts indicate significant 
differences. A) FF piglets had larger DP memory T cell population in PBMC than LF piglets, while SR piglets had an intermediate 
sized DP memory T cell population. B) Diet did not affect DP memory T cell population size in MLN (B) or spleen (C).  
 
 
 
A)       B)          C) 
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Figure 4.7. NK cell populations of piglets by tissue on d21. Piglets were euthanized on d21. Cells were isolated from blood, MLN, 
and spleen and stained with a panel of fluorescently-labeled mAbs targeting CD3, CD4, and CD8 and separated by flow cytometry. 
The data are presented as % of CD3
+
 lymphocyte population and expressed as mean ± SD. Different letter superscripts indicate 
significant differences at p<0.05. NK cell populations were largest in PBMC followed by spleen, then MLN.  
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Figure 4.8. T-cell subpopulations of piglets among tissues. Piglets were euthanized on d21. Cells were isolated from blood, MLN, 
and spleen and stained with a panel of fluorescently-labeled mAbs including CD3, CD4, and CD8. All diet groups in were pooled to 
compare T-cell populations among tissues. The data are presented as % of CD3
+
 lymphocyte population and expressed as mean ± SD. 
Different letter superscripts indicate significant differences. A) MLN had the highest proportion of CD4
+
 helper T-cell populations 
compared to PBMC and spleen. B) The DP memory T-cell population was greater in MLN and spleen than in PBMC. C) The 
proportion of CD8
+
 cytotoxic T-cell population was not different among tissues. 
 
 
 
A)       B)        C) 
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Figure 4.9. NK cell cytotoxicity was higher in SR than LF or FF piglets on d21.  PBMC NK cells were either unstimulated 
(unstim) stimulated with interleukin-2 IL2 (20 ng/mL) or LF (25 ng/mL) and incubated 48 hrs with DiOC18 labeled K562 target cells 
at 37
o
C. Propidium iodide (PI) was added at the end of incubation to label dead cells. Cytotoxicity is reported as killed target 
(PI
+
DiOC18
+
) cells as a percent of total target (DiOC18
+
) cells. No vaccination difference was detected thus vaccinated and non-
vaccinated data were pooled.  Data are expressed as mean ± SD. Lines indicate differences based on stimulation. Different letter 
superscripts indicate significant differences. Ŧ and ƚ indicate differences in a trend. IL2-stimulated NK cells had higher cytotoxic 
activity compared to LF-stimulated and un-stimulated NK cells in all diet groups. Different letter superscripts within stimulants 
indicate significant differences. With IL-2 stimulation, NK cells from SR piglets exhibited greater cytotoxicity compared to those 
from LF piglets with killing by those from FF piglets being intermediary. Un-stimulated NK cells from SR piglets killed with higher 
activity than those from LF and FF animals. A similar pattern was shown with LF-stimulated NK cells; however, differences only 
showed a trend.   
 
NK cell Cytotoxicity: 
Model: p < 0.0001 
Diet: p < 0.0001 
Treatment: p < 0.0001 
Diet*Treatment: p = 0.7056 
NK cell cytotoxicity: 
Model: p < 0.0001 
Diet: p < 0.0001 
Treatment: p < 0.0001 
Diet*Treatment: p = 0.7056 
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Figure 4.10. Interlectin-2 (lactoferrin receptor) mRNA expression in NK cells isolated from PBMCs of piglets on d21. PBMC 
NK cell mRNA was isolated, purified, and gene expression quantified using qRT-PCR. Normalized values for interlectin-2 were 
calculated by dividing the target quantity mean by the Peptidylprolyl Isomerase A quantity mean. A fold-difference was calculated for 
each measurement by dividing the normalized target values by the average normalized target value for formula-fed pigs. All samples 
that were statistically compared to each other were run on the same plate. Data are expressed as mean ± SD of the fold difference 
relative to formula-fed animals. Data with different letter are significantly different at p<0.05. Interlectin-2 mRNA abundance was 
higher in NK cells of LF animals than those of FF or SR. 
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Figure 4.11. Perforin mRNA expression in NK cells isolated from PBMCs of piglets on d21. PBMC NK cell mRNA was isolated, 
purified, and gene expression quantified using qRT-PCR. Normalized values for perforin were calculated by dividing the target 
quantity mean by the Peptidylprolyl Isomerase A quantity mean. A fold-difference was calculated for each measurement by dividing 
the normalized target values by the average normalized target value for formula-fed pigs. All samples that were statistically compared 
to each other were run on the same plate. Data are expressed as mean ± SD of the fold difference relative to formula-fed animals. Data 
with different letter are significantly different at p<0.05. Perforin mRNA abundance was higher in NK cells of SR pigs than those of 
FF or LF. 
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Figure 4.12. NKG2D Receptor mRNA expression in NK cells isolated from PBMCs of piglets on d21.  PBMC NK cell mRNA 
was isolated, purified, and gene expression quantified using qRT-PCR. Normalized values for NKG2D receptor were calculated by 
dividing the target quantity mean by the Peptidylprolyl Isomerase A quantity mean. A fold-difference was calculated for each 
measurement by dividing the normalized target values by the average normalized target value for formula-fed pigs. All samples that 
were statistically compared to each other were run on the same plate. Data are expressed as mean ± SD of the fold difference relative 
to formula-fed animals. Data with different letter are significantly different at p<0.05. SR animals had higher NKG2D receptor mRNA 
abundance in their NK cells than FF animals, while LF animals had an intermediate NKG2D mRNA abundance. 
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 Figure 4.13. IFN-α receptor mRNA expression in NK cells isolated from PBMCs of piglets on d21.  PBMC NK cell mRNA was 
isolated, purified, and quantified using qRT-PCR. Normalized values for IFN-α receptor were calculated by dividing the target 
quantity mean by the Peptidylprolyl Isomerase A quantity mean. A fold-difference was calculated for each measurement by dividing 
the normalized target values by the average normalized target value for formula-fed pigs. All samples that were statistically compared 
to each other were run on the same plate. Data are expressed as mean ± SD of the fold difference relative to formula-fed animals. Data 
with different letter are significantly different at p<0.05. IFN-α receptor mRNA abundance was not affected by diet. 
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Chapter 5 
Discussion, Conclusions and Future Directions 
Discussion 
Lf is a multifunctional milk protein that has antimicrobial properties (Caccavo et al, 
2002) and influences various biological responses including iron metabolism, host defense, 
tumor growth, cell proliferation and differentiation, and enzymatic activity of ribonuclease A 
(Adlerova et al, 2008). It is present in high concentration in mature human milk (2.1 g/L) 
(Adlerova et al, 2008; Masson and Heremans, 1971), but is at 20-fold lower concentration (100 
mg/L) in bovine milk (Krol, 2010) and in infant formula (Statue-Gracia et al, 2000). Due to its 
beneficial biological activities, there is interest in supplementing Lf isolated from bovine milk to 
infant formula. It was shown in Caco-2 cells that a commercially available bLf can bind to the 
human Lf receptor, be internalized into the cell, promote cell proliferation and differentiation, 
influence the expression of transforming growth factor-β1 (TGFβ1), and the secretion of 
interleukin 18 (IL-18) (Lonnerdal et al, 2011).  
Further justifying the addition of Lf to infant formula are several promising clinical trials 
conducted over the past decade.  In a 1-year randomized, placebo-controlled, double-blind study, 
King and colleagues (2007) demonstrated that infants fed formula supplemented with 850 
mgbLf/L (n=26) had significantly fewer lower respiratory tract illnesses and primarily wheezing 
compared to those fed commercial cow milk-based formula containing 102 mg bLf/L (n=26). 
Specifically, the episodes of wheezing were reduced by 3-fold (0.15 vs. 0.5 episodes/y) in the Lf-
supplemented group compared to control.  In addition, infants in the Lf-supplemented group had 
significantly higher hematocrit levels at 9 months (37.1% vs 35.4%; p < 0.05) than infants fed 
the control formula.  
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Turning to effects on immune function, both bovine and human Lf have been shown to 
promote the activation of human T- and B-cell from their naïve precursors and to increase the 
cytotoxic activity of NK cells and lymphokine-activated killer (LAK) cells (Actor et al, 2009). In 
vitro stimulation of NK cells isolated from healthy human adults with hLf demonstrated 
increased NK cell cytotoxicity in the presence of hLf compared to unstimulated NK cells 
(Damiens et al, 1998). 
In this study, the effect of supplemental bLf on T-cell populations, NK cell populations, 
and NK cell cytotoxic activity was examined using the neonatal piglet model. Piglets were fed 1 
g/L or 0.36g bLf/kg BW/day for 21 days. Our data showed that FF and LF animals gained less 
weight compared to SR animals throughout the three weeks of our study. However, this was 
primarily due to the lower rate of weight gain in the first two weeks of the study.  In the final 
week, daily weight gain did not differ between the SR and LF piglets, which were significantly 
higher than the FF group.  On day 21, the body weight of the LF piglets was significantly greater 
than the FF piglets. We do not believe that the FF and LF piglets were growth faltering, rather 
the differences in body weight gain was likely due to the small litter sizes nursing from the sow 
(n= 7-9/litter).  From our experience in other studies, litter sizes of 12-13 piglets are needed in 
order to achieve similar patterns of weight gain in artificially-reared piglets fed at a rate of 360 
ml/kg/d.  The observation that bLF-fed piglets gained more weight in the third week of the study 
is consistent with the study by Humphrey and colleagues (2002) who reported that chicks fed a 
diet containing human Lf and lysozyme showed better feed efficiency (body weight gain/feed 
consumed) than chicks fed the control diet. Furthermore, weaned pigs fed 1g of LF/kg BW had 
improved small intestinal morphology and increased daily weight gain compared to the pigs that 
were fed a control diet (Wang et al, 2006). Lastly, Wakabayashi et al (2004) reported that 
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feeding bLf to mice prevented weight loss following herpes simplex virus type 1 (HSV-1) 
infection. Taken together, these data suggest that bLf supplementation can enhance growth of 
young animals whether healthy or challenged. The mechanism of action whereby Lf increases 
weight gain is not fully understood. Wang and co-workers (2006) demonstrated that weaned pigs 
fed bLF had improved small intestinal morphology, suggesting the potential for improved 
digestion and absorption.  In the current study, there was no difference in intestinal weight of 
length between FF and LF piglets, although more in depth analyses of intestinal structure or 
function was not undertaken.  
 Herein, we studied the individual and combined effects of dietary Lf and Fluzone 
vaccination on NK cell populations and cytotoxicity. This was based on the fact that Paust et al 
(2010) demonstrated that hepatic NK cells develop specific memory to influenza vaccine in 
mice.  Specifically, they demonstrated that recombination-activating gene-1 (RAG1) knockout 
mice immunized with noninfectious virus-like particles (VLPs) from influenza A were able to 
mediate a NK cell response in the hepatocytes 4 weeks later after challenged with influenza 
VLPs (Paust et al, 2010).  In the current study, there was an interaction between diet and 
vaccination status on NK cell population size. The NK cell population of SR piglets was greater 
than FF-NV and did not respond to vaccination.  The NK cell population of FF piglets increased 
after Fluzone
TM
 vaccination to levels similar to SR, which suggests that the NK cells may have 
immunological memory. The NK cell population size of LF piglets was intermediate between SR 
and FF-NV and, similarly to SR did not increase following vaccination.  
 The higher percentage of NK cells in the PBMCs of SR animals than FF animals is 
consistent with the findings of Hawkes et al (1999) and Anderson et al (2009) that demonstrated 
that breast-fed infants had a higher percentage of NK cells in PBMC than formula-fed infants. 
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Thus, NK cell populations are influenced by early nutrition feeding, which  may be attributable 
to components found in human milk that are beneficial for immune development of the neonate 
(Field, 2005).   
On the other hand, the unresponsiveness of NK cell population size to vaccination in LF 
piglets remains unknown. There may be an association between the regulatory role of Lf in 
myeloid cell production and NK cell production. Broxmeyer et al (1980) illustrated that Lf had a 
regulatory role in myelopoiesis in mice by limiting granulocyte-macrophage colony-stimulating 
factor (GM-CSF) secretion and reduce granulocyte and monocyte production. In addition, 
Okamura et al (1991) showed that addition of GM-CSF to NK cell in the presence of IL-2 
obtained a larger number of effector cell in vitro compared to NK cell stimulated with only IL-2. 
Therefore, the presence of Lf may negatively-influence the secretion of GM-CSF, which, in turn, 
may indirectly influence NK cell population size in LF animals. In addition, the memory T-cell 
(CD4
+
CD8
+
) population size in LF piglets was smaller than SR and FF animals, which further 
indicates that Lf may play a regulatory role in immune cell activation. However, neither NK cell 
nor T-cell populations were affected by diet in MLN and spleen. This could be due to lack of 
immunological challenge at those specific organ sites.  
As expected, cell populations differed by organ location. The number of NK cells was 
highest in PBMC followed by spleen and lowest in MLN, suggesting that NK cells are readily 
available in the circulation to encounter and eliminate pathogens. However, CD4
+
 helper T cell 
populations were higher in MLN than in spleen or PBMC. This T-helper cell tissue distribution 
may reflect cell trafficking through these organs. Many foreign antigens are ingested with food 
and therefore first pass through GI tract, and then became absorbed into the system where they 
would traffic to the blood and spleen. We did not determine whether these CD4
+
 helper T cells 
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were producing a TH1, TH2 or T-regulatory response. Since most food antigens are not 
pathogenic, the immune system in the gut may have initiated a T regulatory response to tolerate 
the food antigens (Pulendran et al, 2010) and did not further stimulate an immune response 
systemically. Therefore, especially at birth, when the baby is beginning to tolerate delay antigens 
and intestinal bacteria, large populations of CD4
+
CD3
+
 cells are expected in the MLN. 
Additionally, DP memory T-cell population size was larger in MLN and spleen than PBMC. 
This may also be related to the trafficking of antigens that first enter the system through the GI 
tract and are then filtered by the spleen before entering the blood. An immune response may be 
developed when the antigen passes through the GI tract and spleen. The innate defenders, NK 
cells, predominated in the circulation, while responsive DP T-cells and potentially regulatory 
CD3
+
CD4
+
 cells predominate at the body’s barrier, MLN. 
Diet also had a significant effect on NK cell cytotoxic activity. With IL-2 stimulation, 
NK cell cytotoxicity of LF animals was lower than that of SR animals with cytotoxicity of NK 
cells from FF piglets being intermediate. Even without IL-2 or bLf stimulation, NK cell 
cytotoxicity of LF animals was similar to FF piglets and significantly less than SR piglets.  If Lf 
reduced GM-CSF production (Okamura et al, 1991), this may have reduced NK cell cytotoxicity 
in LF piglets. Thus, oral supplementation of bLf did not increase NK cell cytotoxicity ex vivo. In 
addition, ex vivo stimulation of NK cells with 25 mg/mL of bLf did not increase their 
cytotoxicity compared to unstimulated NK cells in samples from any of the diet groups. Our 
results contradict the findings of Horwitz et al (1983), Kuhara et al (2006), and Shimizu et al 
(1996) who showed that ex vivo stimulation of NK cell with bLf increased NK cell cytotoxic 
activity. Damiens et al (1998) showed that ex vivo stimulation of NK cells isolated from adult 
human with hLf enhanced NK cell cytotoxicity against hematopoietic cells and epithelial tumor 
61 
 
cells, suggesting that human Lf may be effective in enhancing NK cell cytotoxicity.  Other 
studies examined the effect of bLf on NK cell activity were either conducted in mice (Kuhara et 
al, 2006), assisted from other immune cell, which did not use a pure NK cell population in the 
assay (Horwitz et al, 1983; Shimizu et al, 1996), or the mice were immunologically challenged 
with a hapten or virus (Kuhara et al, 2006; Horwitz et al, 1983). Therefore, bLf may not be 
effective in enhancing porcine NK cell activity without assistance from other immune cells or a 
viral/hapten stimulus.  
We also measured interlectin-2 (ITLN-2, LF receptor) mRNA expression in NK cells and 
found that LF piglets had 2.5-fold higher NK cell ITLN-2 mRNA expression than SR or FF 
piglets, suggesting that oral supplementation of bLf may increase LF receptor expression. This 
increase in expression of LF receptors in NK cells theoretically should increase NK cell’s 
responsiveness to bLf stimulation.  However, NK cell cytotoxicity of LF pigs remained as low as 
that of FF pigs after bLf stimulation, which further indicates that Lf may play a role in down- 
regulating NK cell activity. 
Our own preliminary experiments aimed at establishing the optional dose of bLf and 
target-to-effector cell ratio, showed that 25 mg/mL bLf stimulated cytotoxicity of NK cells 
isolated from SR piglets (Appendix A.1B). However, this effect was not observed in our final 
experiment. This may have been due to the different source of animals used in the preliminary 
experiments and the final study.  In the preliminary work, piglets were obtained from the Swine 
Research Center (SRC, University of Illinois), because the animals were readily available. 
However, sows at the SRC were vaccinated against swine influenza virus (SIV), resulting in a 
high amount of SIV-specific antibody being passed to piglets through colostrum, which 
prevented us from detecting a response to the Fluzone
TM
 vaccine. Therefore, sows were 
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purchased from Midwest Research Swine (MRS, Gibbon, MN), because these animals are not 
vaccinated against or exposed to environmental SIV. Unexpectedly, the NK cells from these two 
sources of animals reacted very differently to bLf stimulation in vitro. Herd health may be a 
significant factor differentiating the two sources of pigs. MRS pigs are raised in a fairly 
pathogen-free environment and are not vaccinated, which indicates that they have limited viral or 
bacterial challenges. Animals from the previous studies, which showed an augmentation effect of 
bLf on NK cell cytotoxicity, were either infected with murine cytomegalovirus (MCMV) 
(Shimizu et al, 1996) or NK cells were induced by Polyinosinic-polycytidylic acid (poly [I:C]) 
(Kuhara et al, 2006). This suggests that bLf may enhance NK cell activity to a greater degree in 
immunologically challenged animals. 
The cytotoxicity of NK cells from SR and FF piglets differed. SR piglets had a more 
robust NK cell cytotoxic activity toward the target cells than FF animals even without 
stimulation. With IL-2 stimulation, NK cells from SR animals showed even higher cytotoxcity 
against target cells than those from FF animals. To investigate potential mechanisms for 
improved NK cell cytotoxicty, mRNA expression of perforin, NKG2D receptor, and IFN-α 
receptor was assessed in isolated NK cells. Perforin is a membrane-disrupting protein and an 
essential enabler of granzyme-mediated apoptosis in  target cells (Smyth et al, 2005). Perforin 
deficiency impaired NK cell activity in perforin knockout mice (Kagi et al, 1994). Our data 
showed that perforin mRNA expression in NK cells of SR piglets was 6-fold higher than those of 
FF animals and 3-fold higher than those of LF animals, although expression did not differ 
between LF and FF piglets.  
The NKG2D receptors are killer cell immunoglobulin-like receptors (KIRs) that are 
expressed on the surface of NK cells and mediate NK cell cytotoxicity (Ho et al, 2002) through 
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co-stimulation (Regunathan et al, 2005). Thus, high expression of NKG2D receptor in NK cell 
implies that they are activated (Ferlazzo et al, 2004). The mRNA expression of NKG2D receptor 
was 3.5-fold higher in NK cells of SR animals than FF animals. The mRNA expression of 
NKG2D receptors in NK cells of LF animals was intermediate between those of SR and FF 
animals. Signals from virus-induced IFN-α/β are the major activation source for NK cells against 
viral infection. Thus, type I interferon (IFN-α/β) receptors on NK cells are important for IFN-γ 
production during Herpes Simplex Virus 2 (HSV-2) infection (Gill et al, 2011) and IFN-γ is 
mostly produced by activated NK cells (Milligan and Berstein, 1997). This suggested that IFN-
α/β receptor expression in NK cells could be a good indicator of their degree of activation.  Our 
data showed that diet did not affect IFN-α receptor mRNA expression in NK cells. This may due 
to the constitutive expression of IFN-α receptor on NK cells. IFN-α receptor expression on NK 
cells is constitutive in order to detect the IFN-α/β signaling produced by infected cells. 
Therefore, increased perforin and NKG2D receptors in NK cells from SR pigs may be driving 
the increased cytotoxic activity of those cells. 
 
Conclusions and Future Directions 
 Overall, diet had a significant impact on NK cell population and activity. Piglets that 
were fed mother’s milk had larger NK cell population size and greater cytotoxic activity 
compared to those of FF, which is consistent with the human data showing that breastfed infants 
had a higher percentage of NK cells than formula-fed infants (Anderson et al, 2009; Hawkes et 
al, 1999). In vitro administration of bLf has been shown to have a stimulatory effect on NK cell 
activity in several mouse studies. However, the same effect was not apparent in our study. Thus, 
the overall effects of bLf on the T-cell subpopulations and NK cell development in this study are 
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inconclusive. Many factors could be altering the effect of bLf on NK cell responses, such as the 
source of the animals or the degree of immunological challenge they received; stronger 
immunological challenges may enhance NK cell response to bLf stimulation. For the most part, 
bLf decreased activation of T-cells and NK cell cytotoxic activity. This suggests that bLf may 
play a role in immune regulation. The mechanism of this immunoregulatory effect of bLf in vivo 
is unknown. Future studies are needed to investigate the immune regulatory function of bLf on 
NK cell activity.  
 Our study demonstrated the positive effect of sow milk on innate immune development. 
The increase in cytotoxicity by NK cells from SR piglets over that by cells from FF piglets 
suggesting a potential mechanism whereby sow milk improves the neonatal innate immune 
response. Greater NK cytotoxicity was supported by higher mRNA expression of perforin and 
NKG2D in NK cells from SR animals. It remains to be determined whether it is a specific 
component of sow milk or another aspect of sow-rearing (e.g. contact with the sow and 
littermates) up-regulated NK cell activity and gene expression. In addition, as mRNA expression 
is not a direct measurement of perforin protein, future studies should include intracellular 
staining of perforin to measure the protein content in NK cells of SR and FF piglets before or 
after IL-2 or bLf stimulation. In addition IFN-γ production by NK cells in the different diet 
groups would provide information about the activation status of NK cells. This would help to 
further our understanding of the effect of diet on the development of NK cells and the relevance 
of the isolated porcine NK cell population (CD3
-
CD4
-
CD8
+
) used in this study to CD56
low
CD16
+
 
NK cell population in human, which exhibits cytotoxic activity and IFN-γ production. Though 
we have chosen to test Lf in this study, other components in human milk may be responsible for 
increased NK cell populations and cytotoxic activity in breastfed human infants. Putative milk 
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bioactive for optimal NK cell number and function include dietary nucleotides, which had been 
reported to increase NK cell activity (Field, 2005). 
 Once we obtain a thorough understanding of the differences in responses of NK cells 
from SR vs. FF pigs, this knowledge can be used to design formulas to protect infants from 
infections by promoting optimal NK cell activity. Future work using challenge models, such as 
Staphylococcus aureus or rotavirus infection, will increase our understanding of how sow’s milk 
and bioactive components affect the development of neonatal NK cells under microbial or viral 
infections. These studies would identify specific immune characteristics that could be modulated 
to improve the neonate’s ability to cope with infection. As NK cells are an important first line of 
defense against infection, understanding the factors that increase their number and improve their 
killing ability may enable us to protect formula-fed, and perhaps other immune-compromised 
individuals, from infection. 
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Appendix A 
Optimization of Cytotoxicity Assay for Piglet NK Cells 
 
 NK cells represent an important cell population of the innate immune system due to their 
ability to attach tumor cells and viral-infected cells as well as producing immune-regulatory 
cytokines (Lanier and Phillips, 1992). Lactoferrin, an iron-binding glycoprotein, had been shown 
to increase NK cell cytotoxicity against hematopoietic and breast epithelial cell lines (Damiens et 
al, 1998).  Therefore, we measured NK cell cytotoxic activity in animals fed different diets, SR, 
FF, and LF in this study.  
K562 tumor cells, a human erythroleukemia cell line, were used as the target cell line in 
the NK cell cytotoxicity assay of this study. These non-adherent cells were grown in 75 cm
2
 cell 
culture flask and cell density was adjusted to 2 × 10
5
 cell/mL with complete growth medium 
(ATCC-formulated Iscove’s Modified Dulbecco’s Medium and 10% fetal bovine serum, ATCC, 
Manassas, VA). Medium was changed every other day and cells were counted to maintain a cell 
density at 2 × 10
5
 cells/mL. Cells were grown for 7 days (cell number increased 3-fold) after 
which they were frozen using the Recovery Cell Culture Freezing Medium (Invitrogen Gibco) 
and Mr. Frosty container (Sigma-Aldrich). 
 Prior to the actual study, several preliminary experiments were performed with total of 3 
piglets to determine the optimal concentration of bLf and effector-to-target (E:T) cell ratio to use 
in the study. Two concentrations of bLf (10μg/mL and 25μg/mL) and 3 E:T cell ratios (1:10, 
1:20, and 1:40) were examined. At 10:1 E:T cell ratio, the treatment effect was more obvious 
compared to 20:1 or 40:1 E:T cell ratio (Figure A.1A). Furthermore, it is very difficult to isolate 
sufficient NK cells from PBMCs of neonatal piglets to perform the assay at 20:1 or 40:1 E:T cell 
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ratio. In addition, Toka et al 2009) suggested using no less than 1×10
4
 target cells in order to 
give a more accurate measure of the cytotoxicity. Therefore, 10:1 E:T cell ratio was selected for 
the experiment. Additionally, NK cells that were stimulated with 25μg/mL of bLf at 10:1 E:T 
ratio exhibited a more robust cytotoxic response toward the target cells than NK cells stimulated 
with 10μg/mL of bLf when compared to the unstimulated NK cells (Figure A.1B). Therefore, 
10:1 E:T cell ratio and 25μg/mL bLf were chosen for the actual study. Flow cytometry gating for 
NK cell cytotoxicity measure is shown in Figure A.2. 
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Figure A.1. Establishment of optimal bLf concentration and E:T cell ratio for NK cell cytotoxicity assay. NK cells were isolated 
from 19-day-old sow-reared piglets (n=3). Two concentrations of bLF (LF10: 10μg/mL and LF25: 25μg/mL) and 3 E:T cell ratios 
(10:1, 20:1, and 40:1) were examine in the preliminary experiments. At 10:1 E:T cell ratio, the treatment effect was more obvious 
compared to 20:1 or 40:1 E:T cell ratio (a). NK cells that were stimulated with 25μg/mL of bLf at 10:1 E:T ratio were able to exhibit a 
more robust cytotoxic response toward target cells than NK cells stimulated with 10μg/mL of bLf when compared to the un-stimulated 
NK cells (b). 
 
 
A)         B)
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Figure A.2. Flow cytometry gating for NK cell cytotoxicity assay. All events on side scatter vs. forward scatter were gated. 
PI
+
DiOC18
+
 cells were identified as killed/dead target cells. PI
-
DiOC18
+
 cells were identified as live target cells. Cytotoxicity was 
reported as killed target cells (PI
+
DiOC18
+
) as percent of total target cells (DiOC18
+
). 
 
 
 
 
